Right, and stated more narrowly than I would have dared to state it.
[2026 update] Cardiovascular risk: reading the outcome trials as a set posts 91–104
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
This follows post #89 rather than contradicting it.
Exclusion criteria in the pivotal programmes were specific and are published. Reading the actual criteria is more informative than assuming which conditions were excluded.
I would call that likely rather than established.
I think the Cardiovascular risk question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Where the honest answer is "nobody knows", giving it plainly is more useful than a confident synthesis of mechanism and anecdote.
Everything in post #93 holds. The case it does not cover is the one I have.
Age at the extremes of the studied range is an extrapolation in both directions, and the trials generally studied a narrower band than the discussion assumes.
That is the shape of it. The detail is where I would expect to be corrected.
Cardiovascular risk has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
Thank you for taking the time. That was more work than a reply usually is.
Where two conditions pull in opposite directions, that is a clinical judgement rather than a lookup, and it is the kind of question a forum answers worst.
Adding it because I spent an afternoon working it out and nobody should have to twice.
Post #101 answers the question as asked. The question underneath it is different.
Gastrointestinal conditions interact with a mechanism that slows gastric emptying in ways that are plausible and largely unstudied.
Written in the hope of being told what I have missed.
Helpful, and easy to find again, which is half of what a good reply is.
This topic was referenced in
- Chronic kidney disease and the FLOW resultClinical › Comorbidities · 38 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Type 2 diabetes and the largest part of the evidence base
Posting this under the heading it deserves: Type 2 diabetes and the largest part of the evidence base Everything below is what sits behind that. Trying to work out what would count as evidence on type 2…
|
+81 | 89 | 2.9k | 3mo |
|
Osteoarthritis and mechanical versus metabolic improvement — one year on
On the subject in the title: Osteoarthritis and mechanical versus metabolic improvement — one year on Working notes rather than a conclusion. Collecting what is known about Osteoarthritis and mechanical…
|
+52 | 56 | 8.1k | 15d |
|
Hypertension improvement and when medication needs revisiting
Hypertension improvement and when medication needs revisiting Writing it up because I had to work it out twice and would rather nobody else did. Hypertension improvement: setting out the arithmetic in full,…
|
+74 | 79 | 1.1k | 10mo |
|
Type 2 diabetes and the largest part of the evidence base — does this still hold?
Type 2 diabetes and the largest part of the evidence base — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Trying to work out what would count…
|
+18 | 25 | 1.7k | 22mo |
|
Chronic kidney disease and the FLOW result — a second dataset
Chronic kidney disease and the FLOW result — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. Posting a small dataset on Chronic kidney disease. It is mine,…
|
2 | 2.3k | 20mo |
Related topics — sharing the tags PCOS, type 2 diabetes, chronic kidney disease
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
How much fluid is actually needed, and how you would know
The question in the title: How much fluid is actually needed, and how you would know I will give what I have already checked below so nobody repeats it. Reporting what I changed and what happened, with the…
|
+11 | 15 | 53k | 2mo |
|
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints
On the subject in the title: Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Working notes rather than a conclusion. Working notes on Heart failure with preserved ejection rather…
|
+4 | 8 | 43k | 17mo |
|
What SELECT changed about how semaglutide is discussed, and what it did not
Asking directly, because I could not find a straight answer: What SELECT changed about how semaglutide is discussed, and what it did not I was wrong about SELECT in a thread last spring and I would like to…
|
+120 | 132 | 2k | 14mo |
|
Type 2 diabetes and the largest part of the evidence base
Posting this under the heading it deserves: Type 2 diabetes and the largest part of the evidence base Everything below is what sits behind that. Trying to work out what would count as evidence on type 2…
|
+81 | 89 | 2.9k | 3mo |
|
People with a low starting BMI: where the evidence stops
Posting this under the heading it deserves: People with a low starting BMI: where the evidence stops Everything below is what sits behind that. Asking about a population rather than about a person. The…
|
+23 | 27 | 5.8k | 19mo |